Insulet (NASDAQ:PODD) stock rocketed 27.3% higher in May, according to data from S&P Global Market Intelligence. Shares have pumped out a gain of 38% in 2019 through June 3.
The Massachusetts-based company is the leader in tubeless insulin pump technology with its Omnipod pump.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,